Today's NYSE & NASDAQ Stock Price Targets and Analyst Ratings

Stay on top of the latest NYSE- and NASDAQ-listed stock analyst recommendations with our up-to-date list of stock price targets and analyst ratings. This page tracks newly issued analyst ratings, price targets, upgrades, downgrades, and other broker actions to help you see how Wall Street analysts view U.S. companies. Use these ratings to compare sentiment, spot shifts in outlook, and make more informed investment decisions.

Company	Action	Brokerage	Analyst	Current Price	Price Target	Rating
ECHO Echostar	Upgraded by	Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$91.54 -5.2%		Strong-Buy
FOX FOX	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$51.08 +1.4%		Buy
MDGL Madrigal Pharmaceuticals	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$545.53 -0.9%		Outperform
MS Morgan Stanley	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Keith Horowitz Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$218.37 -4.5%		Neutral
NFLX Netflix	Target Set by	Sanford C. Bernstein Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Laurent Yoon Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$74.35 +0.9%	$95.00
NFLX Netflix	Target Set by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Eric Sheridan Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$74.35 +0.9%	$94.00
OMDA Omada Health	Initiated by	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$23.67 -0.3%		Buy
PTGX Protagonist Therapeutics	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Geoff Meacham Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$132.02 -2.5%		Outperform
ROKU Roku	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jason Bazinet Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$143.82 +0.3%		Neutral
SBAC SBA Communications	Upgraded by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Eric Luebchow Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$185.04 -1.1%		Equal Weight ➝ Overweight
A letter from Shannon Stansberry (Ad) Porter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down year in nearly two decades and total gains of almost 2,000% - his immediate reaction was disbelief. It took a trusted friend's personal vouching for Emmet Savage and a face-to-face trip to Ireland to change his mind. The full documentary, Investigating Project Prophet, is now live. Watch the full story and see the verified track record for yourself
STT State Street	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Emily Ericksen Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$185.15 -0.8%		Buy
TSM Taiwan Semiconductor Manufacturing	Target Set by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Simon Coles Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$408.36 -2.7%	$650.00
USB U.S. Bancorp	Reiterated by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jason Goldberg Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$63.89 +1.4%		Overweight

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Friday at 07:11 AM ET.

Frequently Asked Questions

Analyst ratings are the "buy" and "sell" labels, plus price targets, that investment researchers attach to specific securities. These ratings are based on financial data, earnings reports and conversations with company executives.

Analyst ratings provide plenty of helpful information, but you shouldn't use an analyst's "buy" rating as the sole reason you purchase a security. Analysts aren't immune to conflicts of interest or outside parties' influence, so ensure you always understand why a stock was labeled a "buy" or "sell."

Ratings give investors the analyst's overall opinion about a particular stock and price targets based on the company's valuation and prospects. Analysts often attend conference calls, ask questions and provide in-depth information about companies that are difficult to acquire elsewhere.

NYSE and NASDAQ Stock Price Targets and Analyst Ratings

Frequently Asked Questions

Stock Forecasts and Research Tools

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Price Forecasts for Popular Stocks

Top Stock Recommendations by Brokerage

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

NYSE and NASDAQ Stock Price Targets and Analyst Ratings

Frequently Asked Questions

What are analyst ratings?

Should you trust analyst ratings?

What does an analyst rating tell you about a stock?

Stock Forecasts and Research Tools

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Price Forecasts for Popular Stocks

Top Stock Recommendations by Brokerage

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools